VIVE insider filings

VIVEVE MEDICAL, INC. — 31 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-01-05. Screen VIVE transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for VIVE between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — VIVEVE MEDICAL, INC.

FiledFormInsiderReported transactionsSource
2023-01-054JORN DEBORA — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2023-01-054Presnell Sharon Collins — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2023-01-054Durbin Scott — Chief Executive Officer, DirectorGrant/award (A): 360,000 (derivative) @ $0EDGAR
2023-01-054Basta Steven L — DirectorGrant/award (A): 72,000 (derivative) @ $0EDGAR
2023-01-054Robbins Jim B — SVP, Finance & AdministrationGrant/award (A): 57,000 (derivative) @ $0EDGAR
2023-01-054Morris Arlene — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2022-01-064JORN DEBORA — DirectorGrant/award (A): 22,000 (derivative) @ $0EDGAR
2022-01-064Presnell Sharon Collins — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-01-064Durbin Scott — Chief Executive OfficerGrant/award (A): 258,000 (derivative) @ $0EDGAR
2022-01-064Basta Steven L — DirectorGrant/award (A): 48,000 (derivative) @ $0EDGAR
2022-01-064Robbins Jim B — SVP, Finance & AdministrationGrant/award (A): 42,000 (derivative) @ $0EDGAR
2022-01-064Morris Arlene — DirectorGrant/award (A): 22,000 (derivative) @ $0EDGAR
2021-12-174Durbin Scott — Chief Executive OfficerDisposition to issuer (D): 2 @ $1.40EDGAR
2021-12-174Basta Steven L — DirectorDisposition to issuer (D): 28 @ $1.41EDGAR
2021-12-174Robbins Jim B — SVP, Finance & AdministrationDisposition to issuer (D): 36 @ $1.43EDGAR
2021-06-254JORN DEBORA — DirectorGrant/award (A): 51,700 (derivative) @ $0EDGAR
2021-06-254Presnell Sharon Collins — DirectorGrant/award (A): 39,000 (derivative) @ $0EDGAR
2021-06-254Durbin Scott — Chief Executive Officer, DirectorGrant/award (A): 655,300 (derivative) @ $0EDGAR
2021-06-254Basta Steven L — DirectorGrant/award (A): 116,200 (derivative) @ $0EDGAR
2021-06-254Robbins Jim B — SVP, Finance & AdministrationGrant/award (A): 104,700 (derivative) @ $0EDGAR
2021-06-254Morris Arlene — DirectorGrant/award (A): 51,700 (derivative) @ $0EDGAR
2021-01-224JORN DEBORA — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2021-01-224Presnell Sharon Collins — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2021-01-224Durbin Scott — Chief Executive OfficerGrant/award (A): 243,000 (derivative) @ $0EDGAR
2021-01-224Basta Steven L — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2021-01-224Robbins Jim B — SVP, Finance & AdministrationGrant/award (A): 39,000 (derivative) @ $0EDGAR
2021-01-224Morris Arlene — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2020-10-304Presnell Sharon Collins — DirectorGrant/award (A): 330,000 (derivative) @ $0EDGAR
2020-09-224JORN DEBORA — DirectorGrant/award (A): 165,000 (derivative) @ $0EDGAR
2020-09-224Basta Steven L — DirectorGrant/award (A): 165,000 (derivative) @ $0EDGAR
2020-09-224Morris Arlene — DirectorGrant/award (A): 165,000 (derivative) @ $0EDGAR

Recent 8-K events — VIVEVE MEDICAL, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-01-188-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-01-178-K?
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-158-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-028-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2022-12-018-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-238-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2022-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-10-048-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-09-278-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-09-228-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VIVE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs